These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7287679)

  • 41. Rat heparins. A study of the relative sizes and antithrombin-binding characteristics of heparin proteoglycans, chains and depolymerization products from rat adipose tissue, heart, lungs, peritoneal cavity and skin.
    Horner AA
    Biochem J; 1986 Nov; 240(1):171-9. PubMed ID: 3827837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-function relationships of heparin species.
    Rosenberg RD; Armand G; Lam L
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3065-9. PubMed ID: 277908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sulfated oligosaccharides isolated from the deamination products of heparins.
    Kosakai M; Yosizawa Z
    J Biochem; 1981 Jun; 89(6):1933-44. PubMed ID: 6270073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An active fraction of unfractionated heparin from a natural source is recognized by the first component of the complement system.
    Calabrese GC; Leocatanieto F; Recondo EF; Fernandez de Recondo ME
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL119-23. PubMed ID: 11936856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antithrombin III-Binding Site Analysis of Low-Molecular-Weight Heparin Fractions.
    Chen Y; Zhao J; Yu Y; Liu X; Lin L; Zhang F; Linhardt RJ
    J Pharm Sci; 2018 May; 107(5):1290-1295. PubMed ID: 29339133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel matrix for high performance affinity chromatography and its application in the purification of antithrombin III.
    Zhao R; Luo J; Shangguan D; Liu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):175-81. PubMed ID: 15664348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterogeneity of bovine corneal proteokeratan sulfate.
    Saitoh F; Yamaguchi H
    J Biochem; 1987 Feb; 101(2):453-63. PubMed ID: 2953713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
    Clemmensen I
    Thromb Haemost; 1978 Jun; 39(3):616-23. PubMed ID: 705690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and partial characterization of human plasma depleted of antithrombin-III by heparin-sepharose affinity chromatography.
    Hoogendoorn H; Cerskus A; Ofosu F; Blajchman M; Hirsh J
    Thromb Res; 1980 Oct; 20(1):77-83. PubMed ID: 7209874
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies on a highly potent anticoagulant anionic high molecular weight fraction isolated from porcine heparin.
    Sache E; Choay J; Fareed J
    Ann N Y Acad Sci; 1981; 370():627-43. PubMed ID: 6943973
    [No Abstract]   [Full Text] [Related]  

  • 52. Depolymerization of heparin by complexed ferrous ions.
    Lahiri B; Lai PS; Pousada M; Stanton D; Danishefsky I
    Arch Biochem Biophys; 1992 Feb; 293(1):54-60. PubMed ID: 1731639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural basis for the anticoagulant activity of heparin. 1. Relationship to the number of charged groups.
    Hurst RE; Menter JM; West SS; Settine JM; Coyne EH
    Biochemistry; 1979 Oct; 18(20):4283-7. PubMed ID: 486424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The potency of heparin fractions obtained by gel filtration.
    Hall M; Ricketts CR; Michael SE
    J Pharm Pharmacol; 1969 Sep; 21(9):626-8. PubMed ID: 4390347
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunoadsorbent purification of antithrombin: active form and inactive variants.
    Molloy C; Owen MC; Boswell DR
    Thromb Res; 1989 Sep; 55(5):657-60. PubMed ID: 2683194
    [No Abstract]   [Full Text] [Related]  

  • 56. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.
    Agnelli G; Piovella F; Buoncristiani P; Severi P; Pini M; D'Angelo A; Beltrametti C; Damiani M; Andrioli GC; Pugliese R; Iorio A; Brambilla G
    N Engl J Med; 1998 Jul; 339(2):80-5. PubMed ID: 9654538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N.m.r. and molecular-modelling studies of the solution conformation of heparin.
    Mulloy B; Forster MJ; Jones C; Davies DB
    Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):849-58. PubMed ID: 8352752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specificity studies on the heparin lyases from Flavobacterium heparinum.
    Desai UR; Wang HM; Linhardt RJ
    Biochemistry; 1993 Aug; 32(32):8140-5. PubMed ID: 8347612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. History of drugs for thrombotic disease. Discovery, development, and directions for the future.
    Mueller RL; Scheidt S
    Circulation; 1994 Jan; 89(1):432-49. PubMed ID: 8281678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formation of anhydrosugars in the chemical depolymerization of heparin.
    Shively JE; Conrad HE
    Biochemistry; 1976 Sep; 15(18):3932-42. PubMed ID: 9127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.